Peer Review reports
From: HYAL3 as a potential novel marker of BLCA patient prognosis
Original Submission | ||
---|---|---|
4 Mar 2022 | Submitted | Original manuscript |
Resubmission - Version 2 | ||
Submitted | Manuscript version 2 | |
7 Apr 2022 | Reviewed | Reviewer Report |
15 Apr 2022 | Reviewed | Reviewer Report |
24 May 2022 | Author responded | Author comments - Hao Lin |
Resubmission - Version 3 | ||
24 May 2022 | Submitted | Manuscript version 3 |
30 May 2022 | Author responded | Author comments - Hao Lin |
Resubmission - Version 4 | ||
30 May 2022 | Submitted | Manuscript version 4 |
2 Jun 2022 | Author responded | Author comments - Hao Lin |
Resubmission - Version 5 | ||
2 Jun 2022 | Submitted | Manuscript version 5 |
16 Jun 2022 | Reviewed | Reviewer Report |
20 Jun 2022 | Reviewed | Reviewer Report |
4 Jul 2022 | Author responded | Author comments - Hao Lin |
Resubmission - Version 6 | ||
4 Jul 2022 | Submitted | Manuscript version 6 |
Publishing | ||
8 Jul 2022 | Editorially accepted | |
9 Aug 2022 | Article published | 10.1186/s12863-022-01070-w |
You can find further information about peer review here.